Preferentially immunoglobulin (IgG) subclasses production in primary Söjgren's syndrome patients

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 2, 2012, Pages 345-349

  Liu, Yudong ^a,b   Li, Jinming ^a,b  

^a BEIJING HOSPITAL   (China)

^b GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

autoantibodies; IgG subclass concentrations; immunonephelometric assay; primary Sj gren's syndrome.

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; SJOEGREN SYNDROME;

EID: 84860508488     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.771     Document Type: Article

References (19)

1. Fox RI. Sjögren's syndrome. Lancet 2005;366:321-31.
2. Lindström FD, Eriksson P, Tejle K, Skogh T. IgG subclasses of anti-SS-A/Ro in patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1994; 73: 358-61. (Pubitemid 24380131)
3. Routsias JG, Tzioufas AG. Sjögren's syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol 2007;32:238-51.
4. Eriksson P, Almroth G, Denneberg T, Lindström FD. IgG2 defi-ciency in primary Sjögren's syndrome and hypergammaglobu-linemic purpura. Clin Immunol Immunopathol 1994;70:60-5. (Pubitemid 24034690)
5. Maran R, Dueymes M, Pennec YL, Casburn-Budd R, Shoenfeld Y, Youinou P. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome. J Autoimmun 1993;6:379-87. (Pubitemid 23214961)
6. Goëb V, Salle V, Duhaut P, Jouen F, Smail A, Ducroix JP, et al. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Clin Exp Immunol 2007; 148: 281-7. (Pubitemid 46587585)
7. Tao MH, Smith RI, Morrison SL. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med 1993;178:661-7. (Pubitemid 23218215)
8. Woof JM, Burton DR. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol 2004;4:89-99. (Pubitemid 38209203)
9. Pressac M, Allouche F, Circaud R, Aymard P. Evaluation of human IgG subclass assays on Beckman array. Ann Clin Biochem 1995;32:281-8.
10. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
11. Nikolov NP, Illei GG. Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol 2009;21:465-70.
12. Mitsdoerffer M, Lee Y, J ä ger A, Kim HJ, Korn T, Kolls JK, et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA 2010;107:14292-7.
13. Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 2011;13:227-36.
14. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM. Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol 2009;175:1167-77.
15. + regulatory T cells in human thymus and periphery. Immunity 2008;28:870-80.
16. Kawano Y, Noma T, Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994;153:4948-58. (Pubitemid 24356126)
17. Dias C, Isenberg DA. Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nat Rev Rheumatol 2011;7:360-8.
18. Hansen A, Lipsky PE, Dörner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 2007;3:561-9. (Pubitemid 47514471)
19. Shin MS, Lee N, Kang I. Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells. Curr Opin Rheumatol 2011;23:444-8.